Therapy after single oral agent failure: adding a second oral agent or an insulin mixture?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.DIABRES.2003.08.003PMID 14625133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.

  2001cited by this paper
• What is the real contribution of fasting plasma glucose and postprandial glucose in predicting HbA(1c) and overall blood glucose control?

  2001cited by this paper
• Postprandial blood glucose. American Diabetes Association.

  2001cited by this paper
• Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis.

  2001cited by this paper
• Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?

  2000cited by this paper
• Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

  2000cited by this paper
• Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

  1999cited by this paper
• Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment

  1997cited by this paper
• Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

  1997cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• STATISTICAL METHODS

  1967cited by this paper

• Network meta-analysis of glucose-lowering drug treatment regimens with the potential risk of hypoglycemia in patients with type 2 diabetes mellitus in terms of glycemic control and severe hypoglycemia

  2023cites this paper
• Resource utilization and costs associated with using insulin therapy within a newly diagnosed type 2 diabetes mellitus population.

  2015cites this paper
• The Effect of Adjusting for Baseline Hypoglycemia when Analyzing Hypoglycemia Data: A Systematic Analysis of 15 Diabetes Clinical Trials

  2013cites this paper
• Efficacy and safety of insulin treatment in type 2 diabetes using a new index called glucose safety control index

  2013cites this paper
• Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data

  2012influential citation
• AHRQ’s Comparative Effectiveness Research on Oral Medications for Type 2 Diabetes: A Summary of the Key Findings

  2012cites this paper
• Humalog (lispro) for type 2 diabetes

  2012influential citation
• Table of Contents AHRQ ’ s Comparative Effectiveness Research on Oral Medications for Type 2 Diabetes : A Summary of the Key Findings

  2012cites this paper
• Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta‐analysis of randomised controlled trials

  2011cites this paper
• AHRQ's Comparative Effectiveness Research on Premixed Insulin Analogues for Adults with Type 2 Diabetes: Understanding and Applying the Systematic Review Findings

  2011cites this paper
• Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: a systematic review.

  2011influential citation
• Insulin Analogs and Glycosylated Hemoglobin Target of Less Than 7% in Type 2 Diabetes: A Systematic Review of Randomized Trials

  2011cites this paper
• Bundesärztekammer Kassenärztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften

  2011cites this paper
• Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review.

  2011cites this paper
• Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes.

  2010influential citation
• Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitus.

  2010cites this paper
• Insulin lispro protamine suspension in intensive insulin treatment: an Italian observational study

  2009cites this paper
• Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes

  2008influential citation
• Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis.

  2008cites this paper
• Inhaled human insulin (Exubera®): clinical profile and patient considerations

  2007cites this paper
• Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness

  2007influential citation
• Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs.

  2007cites this paper
• Physiological and Behavioral Aspects of Glycemic Control and Hypoglycemia in Diabetes

  2007cites this paper
• Canadian Agency for Drugs and Technologies in Health Short-acting Insulin Analogues for Diabetes Mellitus

  2007influential citation
• Inhaled Human Insulin (Exubera ® ): An Opportunity for Improving Long- Term Glycaemic Control in Patients with Diabetes?

  2006cites this paper
• Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting

  2005cites this paper
• Oral Insulin Enhances Intestinal Regrowth Following Massive Small Bowel Resection in Rat

  2005cites this paper
• Inha led Human Insu l in ( Exubera ® ) :

  year unknowncites this paper